Literature DB >> 12635015

[Diffusion-weighted MRI--a new parameter for advanced rectal carcinoma?].

P A Hein1, C Kremser, W Judmaier, J Griebel, A Rudisch, K-P Pfeiffer, E B Hug, P Lukas, A F DeVries.   

Abstract

PURPOSE: To evaluate the predictive value of apparent diffusion coefficient (ADC) on therapy outcome of combined chemoradiation in patients with primary carcinoma of the rectum. MATERIALS AND
METHOD: Prior to standardized, combined, neoadjuvant chemoradiation, 16 patients with primary carcinoma of the rectum (cT3) were examined with magnetic resonance imaging (MRI). Diffusion-weighted spin echo echo-planar images (SE-EPI) and contrast-enhanced T 1 -weighted spin echo (SE) images at 1.5 Tesla were obtained. The mean ADC of the tumor region was calculated and correlated with the therapy outcome substantiated by postsurgical histopathologic staging.
RESULTS: Tumor down-staging (pT0-2) occurred in 9 patients (therapy responders) and no down-staging (pT3) in 7 patients (therapy non-responders). The mean ADC measured 0.476 +/- 0.114 x 10(-3) mm 2/s in the responder group and 0.703 +/- 0.085 x 10(-3) mm 2/s in the non-responder group. Comparison of the mean ADC between the groups reached statistical significance (p = 0.001).
CONCLUSION: The mean ADC might be a new quantitative parameter to predict therapy outcome of combined preoperative chemoradiation in patients with primary carcinoma of the rectum.

Entities:  

Mesh:

Year:  2003        PMID: 12635015     DOI: 10.1055/s-2003-37836

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

Review 1.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

2.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI.

Authors:  Yael Mardor; Yiftach Roth; Aharon Ochershvilli; Roberto Spiegelmann; Thomas Tichler; Dianne Daniels; Stephan E Maier; Ouzi Nissim; Zvi Ram; Jacob Baram; Arie Orenstein; Raphael Pfeffer
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

3.  The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging.

Authors:  Maria-Katharina Ganten; Maximilian Schuessler; Tobias Bäuerle; Marc Muenter; Heinz-Peter Schlemmer; Alexandra Jensen; Karsten Brand; Margret Dueck; Julien Dinkel; Annette Kopp-Schneider; Klaus Fritzsche; Bram Stieltjes
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

4.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.

Authors:  Li Zhu; Lijing Zhu; Hua Shi; Huanhuan Wang; Jing Yan; Baorui Liu; Weibo Chen; Jian He; Zhengyang Zhou; Xiaofeng Yang; Tian Liu
Journal:  BMC Cancer       Date:  2016-02-10       Impact factor: 4.430

5.  Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.

Authors:  Mengjing Zhao; Lihao Zhao; Han Yang; Yuxia Duan; Gang Li
Journal:  Radiat Oncol       Date:  2021-01-20       Impact factor: 3.481

6.  Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma.

Authors:  Daniela Musio; Francesca De Felice; Anna Lisa Magnante; Maria Ciolina; Carlo Nicola De Cecco; Marco Rengo; Adriano Redler; Andrea Laghi; Nicola Raffetto; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2013-07-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.